Literature DB >> 12810713

Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors.

Cheng Song1, Yuntian Zhang, Chris G Parsons, Ya Fang Liu.   

Abstract

In our previous studies, we found that expression of polyglutamine-expanded huntingtin in HN33 cells induced sensitization of N-methyl-D-aspartate (NMDA) receptors (Sun, Y., Savinainen, A., and Liu, Y. F. (2001) J. Biol. Chem. 276, 24713-24718). Following this study, we investigated whether tyrosine phosphorylation of NMDA receptors might contribute to the altered property of the receptors. Expression of polyglutamine-expanded huntingtin induced elevation of phosphorylated or activated Src and increased targeting of PSD-95 (post-synaptic density 95) and activated Src to cell surface membrane. Expression of the mutated huntingtin also induced tyrosine phosphorylation of NR2B (NMDA receptor 2B) subunits, and co-expression of PSD-95 enhanced the phosphorylation. Treatment of SU6656 (a specific Src inhibitor) or co-expression of a mutated NR2B subunit with mutations of all three major tyrosine phosphorylation sites significantly attenuated neuronal toxicity induced by the mutated huntingtin. Addition of AP-5 did not further inhibit the neuronal toxicity. Taken together, our studies show that polyglutamine-expanded huntingtin increases tyrosine phosphorylation of NMDA receptors via PSD-95 and Src, and increased tyrosine phosphorylation may contribute to the sensitization of the receptors mediated by polyglutamine-expanded huntingtin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810713     DOI: 10.1074/jbc.M304240200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  The Huntington's disease mutation impairs Huntingtin's role in the transport of NF-κB from the synapse to the nucleus.

Authors:  Edoardo Marcora; Mary B Kennedy
Journal:  Hum Mol Genet       Date:  2010-08-25       Impact factor: 6.150

Review 2.  Insights into Computational Drug Repurposing for Neurodegenerative Disease.

Authors:  Manish D Paranjpe; Alice Taubes; Marina Sirota
Journal:  Trends Pharmacol Sci       Date:  2019-07-17       Impact factor: 14.819

3.  Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats.

Authors:  Harikesh Kalonia; Jitendriya Mishra; Anil Kumar
Journal:  Neurotox Res       Date:  2012-03-06       Impact factor: 3.911

4.  Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors.

Authors:  Antonio Sanz-Clemente; Jose A Matta; John T R Isaac; Katherine W Roche
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

5.  Immunohistochemical localization of AMPA-type glutamate receptor subunits in the striatum of rhesus monkey.

Authors:  Yun-Ping Deng; Evan Shelby; Anton J Reiner
Journal:  Brain Res       Date:  2010-05-09       Impact factor: 3.252

6.  NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.

Authors:  Larissa Arning; Peter H Kraus; Sandra Valentin; Carsten Saft; Jürgen Andrich; Jörg T Epplen
Journal:  Neurogenetics       Date:  2004-11-17       Impact factor: 2.660

7.  Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease.

Authors:  Jiu-Qiang Wang; Qian Chen; Xianhua Wang; Qiao-Chu Wang; Yun Wang; He-Ping Cheng; Caixia Guo; Qinmiao Sun; Quan Chen; Tie-Shan Tang
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

8.  Tetrabenazine is neuroprotective in Huntington's disease mice.

Authors:  Hongyu Wang; Xi Chen; Yuemei Li; Tie-Shan Tang; Ilya Bezprozvanny
Journal:  Mol Neurodegener       Date:  2010-04-26       Impact factor: 14.195

Review 9.  Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases.

Authors:  Xiao-xia Dong; Yan Wang; Zheng-hong Qin
Journal:  Acta Pharmacol Sin       Date:  2009-04       Impact factor: 6.150

10.  Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.

Authors:  Tie-Shan Tang; Xi Chen; Jing Liu; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2007-07-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.